Contrast ultrasound for uterine fibroids before and after UAE
Part of Cancer clinical trials.
This trial uses special contrast-enhanced ultrasound (CEUS and SHAPE) to take detailed images of uterine fibroids before and after a procedure called uterine artery embolization (UAE). It aims to help doctors better understand how fibroids respond to treatment.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You have endometrial cancer and are scheduled for a treatment called uterine artery embolization (UAE).
- You are at least 18 years old.
- If you could become pregnant, you must have a negative pregnancy test.
- You are able to follow study instructions and provide written consent.
- You are not pregnant or nursing.
- You have not taken an experimental drug in the last 30 days or will not need one within 72 hours after the study ultrasound.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial tests a new particle material, Bearing nsPVA, for uterine artery embolization (UAE), a procedure that blocks blood flow to fibroids to shrink them and reduce symptoms like heavy bleeding or pain. It aims to see if this material is safe and effective for women with symptomatic fibroids.
This study tests whether a special ultrasound with a contrast dye can help doctors find clinically significant prostate cancer during a biopsy. The goal is to better target the biopsy, which may lead to more accurate diagnosis.
This trial tests a gentle electrical stimulation treatment placed near the cervix to see if it can reduce pelvic pain after a procedure called uterine fibroid embolization, which is used to shrink fibroids. It aims to give better pain relief during recovery.
This study is looking at whether a computer program (artificial intelligence) can help doctors better evaluate how well uterine artery embolization (UAE) worked for treating fibroids. The program analyzes the X-ray images taken during the procedure to see if it might improve outcomes for women with fibroids.
This trial tests a new, detailed ultrasound technique that uses a contrast agent (called Definity) to get clearer images of a suspicious area before a biopsy. It may help doctors better see the blood flow in the lesion, which could improve diagnosis.
This trial compares two treatments for painful or heavy menstrual bleeding caused by uterine fibroids: high-intensity focused ultrasound (HIFU) and myomectomy (surgery to remove fibroids). It may help you decide which option fits your needs.
Hear when a new Uterine Fibroid trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.